Eli Lilly And Company ($LLY) announced an update on their ongoing clinical study. Eli Lilly and Company is conducting a Phase ...
No increased risk for cancer was found among patients with RA receiving biologic or targeted synthetic DMARDs vs TNF inhibitors.
Adaptive Biotechnologies said on Monday it has signed two non-exclusive deals with Pfizer to support research in rheumatoid ...
Neuroimmune modulation inhibited progression of structural damage in patients with rheumatoid arthritis who had inadequate response or intolerance to DMARD therapy, according to data presented at ACR ...
Neuroimmune modulation could be an “emerging therapeutic approach” for patients with rheumatoid arthritis who had incomplete response or intolerance to anti-TNF therapy, according to Minna Kohler, MD, ...
Use of disease-modifying anti-rheumatic drugs (DMARDs) for rheumatoid arthritis (RA) was markedly lower among all major racial-ethnic minority groups in the U.S. compared with white patients, analysis ...
On February 2, 2024, the voices of many people who have rheumatoid disease will be heard. Rheumatoid disease, also known as rheumatoid arthritis (RA), is an autoimmune condition in which the body ...
Air pollution might play a role in people's risk for developing autoimmune diseases like lupus and rheumatoid arthritis, a ...
Online resources, such as blogs and apps, can help individuals with rheumatoid arthritis to connect with others, track symptoms, and manage their condition. Online forums and Facebook groups provide ...
Rheumatoid arthritis can make it uncomfortable to work out, but there are many benefits to being physically active when you have this condition. Exercise and stretching can ease joint pain, help make ...
Review of recent advances in biomimetic drug delivery for rheumatoid arthritis, highlighting targeted nanomedicine strategies, mechanisms, and translational challenges for safer, more effective long ...
Pauciarticular juvenile rheumatoid arthritis (PJRA), also known as oligoarticular juvenile idiopathic arthritis (JIA), is a type of arthritis that affects children under 16. It causes inflammation in ...